547 related articles for article (PubMed ID: 10952413)
1. Isolation and characterization of monoclonal antibodies specific for protein conformational epitopes present in prostate-specific membrane antigen (PSMA).
Tino WT; Huber MJ; Lake TP; Greene TG; Murphy GP; Holmes EH
Hybridoma; 2000 Jun; 19(3):249-57. PubMed ID: 10952413
[TBL] [Abstract][Full Text] [Related]
2. In vitro characterization of radiolabeled monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen.
Smith-Jones PM; Vallabahajosula S; Goldsmith SJ; Navarro V; Hunter CJ; Bastidas D; Bander NH
Cancer Res; 2000 Sep; 60(18):5237-43. PubMed ID: 11016653
[TBL] [Abstract][Full Text] [Related]
3. Isolation and characterization of monoclonal antibodies specific for the extracellular domain of prostate specific membrane antigen.
Murphy GP; Greene TG; Tino WT; Boynton AL; Holmes EH
J Urol; 1998 Dec; 160(6 Pt 2):2396-401. PubMed ID: 9817391
[TBL] [Abstract][Full Text] [Related]
4. Measurement of serum prostate-specific membrane antigen, a new prognostic marker for prostate cancer.
Murphy GP; Kenny GM; Ragde H; Wolfert RL; Boynton AL; Holmes EH; Misrock SL; Bartsch G; Klocker H; Pointner J; Reissigl A; McLeod DG; Douglas T; Morgan T; Gilbaugh J
Urology; 1998 May; 51(5A Suppl):89-97. PubMed ID: 9610563
[TBL] [Abstract][Full Text] [Related]
5. Radiolabeled monoclonal antibodies specific to the extracellular domain of prostate-specific membrane antigen: preclinical studies in nude mice bearing LNCaP human prostate tumor.
Smith-Jones PM; Vallabhajosula S; Navarro V; Bastidas D; Goldsmith SJ; Bander NH
J Nucl Med; 2003 Apr; 44(4):610-7. PubMed ID: 12679407
[TBL] [Abstract][Full Text] [Related]
6. Measurement of prostate-specific membrane antigen in the serum with a new antibody.
Murphy GP; Tino WT; Holmes EH; Boynton AL; Erickson SJ; Bowes VA; Barren RJ; Tjoa BA; Misrock SL; Ragde H; Kenny GM
Prostate; 1996 Apr; 28(4):266-71. PubMed ID: 8602402
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibodies to the extracellular domain of prostate-specific membrane antigen also react with tumor vascular endothelium.
Liu H; Moy P; Kim S; Xia Y; Rajasekaran A; Navarro V; Knudsen B; Bander NH
Cancer Res; 1997 Sep; 57(17):3629-34. PubMed ID: 9288760
[TBL] [Abstract][Full Text] [Related]
8. Identification, purification, and subcellular localization of prostate-specific membrane antigen PSM' protein in the LNCaP prostatic carcinoma cell line.
Grauer LS; Lawler KD; Marignac JL; Kumar A; Goel AS; Wolfert RL
Cancer Res; 1998 Nov; 58(21):4787-9. PubMed ID: 9809977
[TBL] [Abstract][Full Text] [Related]
9. Five different anti-prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated neovasculature.
Chang SS; Reuter VE; Heston WD; Bander NH; Grauer LS; Gaudin PB
Cancer Res; 1999 Jul; 59(13):3192-8. PubMed ID: 10397265
[TBL] [Abstract][Full Text] [Related]
10. Identification of prostate specific membrane antigen (PSMA) as the target of monoclonal antibody 107-1A4 by proteinchip; array, surface-enhanced laser desorption/ionization (SELDI) technology.
Wang S; Diamond DL; Hass GM; Sokoloff R; Vessella RL
Int J Cancer; 2001 Jun; 92(6):871-6. PubMed ID: 11351309
[TBL] [Abstract][Full Text] [Related]
11. Induction of antibodies against prostate-specific membrane antigen (PSMA) by vaccination with a PSMA DNA vector.
Kuratsukuri K; Wang CY; Sone T; Nishisaka N; Jones RF; Haas GP
Eur Urol; 2002 Jul; 42(1):67-73. PubMed ID: 12121733
[TBL] [Abstract][Full Text] [Related]
12. Preparation and characterization of new anti-PSMA monoclonal antibodies with potential clinical use.
Moffett S; Mélançon D; DeCrescenzo G; St-Pierre C; Deschénes F; Saragovi HU; Gold P; Cuello AC
Hybridoma (Larchmt); 2007 Dec; 26(6):363-72. PubMed ID: 18158780
[TBL] [Abstract][Full Text] [Related]
13. Novel Monoclonal Antibodies Recognizing Human Prostate-Specific Membrane Antigen (PSMA) as Research and Theranostic Tools.
Nováková Z; Foss CA; Copeland BT; Morath V; Baranová P; Havlínová B; Skerra A; Pomper MG; Barinka C
Prostate; 2017 May; 77(7):749-764. PubMed ID: 28247415
[TBL] [Abstract][Full Text] [Related]
14. Prostate-specific membrane antigen: a novel folate hydrolase in human prostatic carcinoma cells.
Pinto JT; Suffoletto BP; Berzin TM; Qiao CH; Lin S; Tong WP; May F; Mukherjee B; Heston WD
Clin Cancer Res; 1996 Sep; 2(9):1445-51. PubMed ID: 9816319
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of prostate-specific membrane antigen (PSMA)-positive tumor growth by vaccination with either full-length or the C-terminal end of PSMA.
Kuratsukuri K; Sone T; Wang CY; Nishisaka N; Jones RF; Haas GP
Int J Cancer; 2002 Nov; 102(3):244-9. PubMed ID: 12397643
[TBL] [Abstract][Full Text] [Related]
16. Purification of prostate-specific membrane antigen using conformational epitope-specific antibody-affinity chromatography.
Liu T; Toriyabe Y; Berkman CE
Protein Expr Purif; 2006 Oct; 49(2):251-5. PubMed ID: 16815035
[TBL] [Abstract][Full Text] [Related]
17. Screening of HLA-A24-restricted epitope peptides from prostate-specific membrane antigen that induce specific antitumor cytotoxic T lymphocytes.
Horiguchi Y; Nukaya I; Okazawa K; Kawashima I; Fikes J; Sette A; Tachibana M; Takesako K; Murai M
Clin Cancer Res; 2002 Dec; 8(12):3885-92. PubMed ID: 12473604
[TBL] [Abstract][Full Text] [Related]
18. Prostate-specific membrane antigen (PSMA)-specific monoclonal antibodies in the treatment of prostate and other cancers.
Gong MC; Chang SS; Sadelain M; Bander NH; Heston WD
Cancer Metastasis Rev; 1999; 18(4):483-90. PubMed ID: 10855791
[TBL] [Abstract][Full Text] [Related]
19. Three conformational antibodies specific for different PSMA epitopes are promising diagnostic and therapeutic tools for prostate cancer.
Wolf P; Freudenberg N; Bühler P; Alt K; Schultze-Seemann W; Wetterauer U; Elsässer-Beile U
Prostate; 2010 Apr; 70(5):562-9. PubMed ID: 19938014
[TBL] [Abstract][Full Text] [Related]
20. PSMA mimotope isolated from phage displayed peptide library can induce PSMA specific immune response.
Zhu ZY; Zhong CP; Xu WF; Lin GM; Ye GQ; Ji YY; Sun B; Yeh M
Cell Res; 1999 Dec; 9(4):271-80. PubMed ID: 10628836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
